Lucira Health (NASDAQ:LHDXQ – Get Rating) is one of 42 public companies in the “Diagnostic substances” industry, but how does it compare to its peers? We will compare Lucira Health to similar companies based on the strength of its earnings, profitability, valuation, institutional ownership, dividends, analyst recommendations and risk.
Valuation & Earnings
This table compares Lucira Health and its peers revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Net Income | Price/Earnings Ratio | |
| Lucira Health | $93.06 million | -$64.83 million | -0.06 |
| Lucira Health Competitors | $466.41 million | $9.97 million | -53.79 |
Lucira Health’s peers have higher revenue and earnings than Lucira Health. Lucira Health is trading at a higher price-to-earnings ratio than its peers, indicating that it is currently more expensive than other companies in its industry.
Risk and Volatility
Insider and Institutional Ownership
57.0% of Lucira Health shares are held by institutional investors. Comparatively, 45.4% of shares of all “Diagnostic substances” companies are held by institutional investors. 30.4% of Lucira Health shares are held by insiders. Comparatively, 14.1% of shares of all “Diagnostic substances” companies are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Profitability
This table compares Lucira Health and its peers’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Lucira Health | -67.54% | -13.55% | -8.47% |
| Lucira Health Competitors | -1,428.77% | -106.08% | -26.85% |
Analyst Ratings
This is a summary of current ratings for Lucira Health and its peers, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Lucira Health | 0 | 0 | 0 | 0 | N/A |
| Lucira Health Competitors | 328 | 618 | 1230 | 19 | 2.43 |
As a group, “Diagnostic substances” companies have a potential upside of 36.61%. Given Lucira Health’s peers higher possible upside, analysts clearly believe Lucira Health has less favorable growth aspects than its peers.
Summary
Lucira Health beats its peers on 6 of the 9 factors compared.
Lucira Health Company Profile
Lucira Health Inc. is a medical technology company. It is focused on the development and commercialization of transformative and infectious disease test kits. Lucira Health Inc. is based in Emeryville, California.
Receive News & Ratings for Lucira Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lucira Health and related companies with MarketBeat.com's FREE daily email newsletter.
